LDHA and neoplasm: NADH-competitive inhibitors of LDHA, such as Gossypol (also known as AT-101), FX11 (3-dihydroxy-6-methyl-7-(phenylmethyl)-4-propylnaphthalene-1-carboxylic acid), and quinoline-3-sulfonamide, have also been proven to inhibit tumor cell proliferation (Van Poznak et al., 2001; Billiard et al., 2013).